Jason Wittes
Stock Analyst at Roth MKM
(3.52)
# 924
Out of 4,761 analysts
57
Total ratings
53.06%
Success rate
5.53%
Average return
Main Sectors:
Stocks Rated by Jason Wittes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRMD IRADIMED CORPORATION | Reiterates: Buy | $60 → $72 | $56.24 | +28.02% | 3 | Feb 14, 2025 | |
| TLSI TriSalus Life Sciences | Reiterates: Buy | $11 | $5.77 | +90.64% | 2 | Jan 24, 2025 | |
| GMED Globus Medical | Maintains: Buy | $100 → $115 | $80.28 | +43.25% | 4 | Dec 17, 2024 | |
| MGRM Monogram Technologies | Initiates: Buy | $4 | $2.32 | +72.41% | 1 | Dec 9, 2024 | |
| OFIX Orthofix Medical | Reiterates: Buy | $20 → $22 | $17.95 | +22.56% | 4 | Nov 8, 2024 | |
| ALUR Allurion Technologies | Initiates: Buy | $50 | $3.55 | +1,308.45% | 1 | Sep 6, 2024 | |
| MNMD Mind Medicine (MindMed) | Maintains: Buy | $36 | $7.63 | +371.82% | 1 | Jul 24, 2024 | |
| DERM Journey Medical | Reinstates: Buy | $11 | $5.19 | +111.95% | 1 | Jun 28, 2024 | |
| CRDL Cardiol Therapeutics | Initiates: Buy | $10 | $1.20 | +733.33% | 1 | Jun 26, 2024 | |
| LMAT LeMaitre Vascular | Reinstates: Buy | $100 | $99.54 | +0.46% | 1 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.62 | +517.28% | 2 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $348 → $405 | $382.78 | +5.80% | 10 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $2.20 | +127.27% | 4 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $2.11 | +326.54% | 2 | Feb 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $42.71 | +75.60% | 2 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $10.61 | +107.35% | 3 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $120 | $104.83 | +14.47% | 7 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $206 | $169.96 | +21.20% | 1 | Sep 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $145 | $191.21 | -24.17% | 1 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $10.75 | +39.53% | 2 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $200 | $22.09 | +805.39% | 3 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $30.88 | -15.80% | 1 | Feb 22, 2017 |
IRADIMED CORPORATION
Feb 14, 2025
Reiterates: Buy
Price Target: $60 → $72
Current: $56.24
Upside: +28.02%
TriSalus Life Sciences
Jan 24, 2025
Reiterates: Buy
Price Target: $11
Current: $5.77
Upside: +90.64%
Globus Medical
Dec 17, 2024
Maintains: Buy
Price Target: $100 → $115
Current: $80.28
Upside: +43.25%
Monogram Technologies
Dec 9, 2024
Initiates: Buy
Price Target: $4
Current: $2.32
Upside: +72.41%
Orthofix Medical
Nov 8, 2024
Reiterates: Buy
Price Target: $20 → $22
Current: $17.95
Upside: +22.56%
Allurion Technologies
Sep 6, 2024
Initiates: Buy
Price Target: $50
Current: $3.55
Upside: +1,308.45%
Mind Medicine (MindMed)
Jul 24, 2024
Maintains: Buy
Price Target: $36
Current: $7.63
Upside: +371.82%
Journey Medical
Jun 28, 2024
Reinstates: Buy
Price Target: $11
Current: $5.19
Upside: +111.95%
Cardiol Therapeutics
Jun 26, 2024
Initiates: Buy
Price Target: $10
Current: $1.20
Upside: +733.33%
LeMaitre Vascular
May 31, 2024
Reinstates: Buy
Price Target: $100
Current: $99.54
Upside: +0.46%
May 16, 2024
Reiterates: Buy
Price Target: $10
Current: $1.62
Upside: +517.28%
May 1, 2024
Maintains: Buy
Price Target: $348 → $405
Current: $382.78
Upside: +5.80%
Mar 5, 2024
Reiterates: Buy
Price Target: $5
Current: $2.20
Upside: +127.27%
Feb 13, 2024
Initiates: Buy
Price Target: $9
Current: $2.11
Upside: +326.54%
Oct 20, 2023
Initiates: Buy
Price Target: $75
Current: $42.71
Upside: +75.60%
Oct 20, 2023
Initiates: Buy
Price Target: $22
Current: $10.61
Upside: +107.35%
Oct 20, 2023
Initiates: Neutral
Price Target: $120
Current: $104.83
Upside: +14.47%
Sep 14, 2022
Initiates: Buy
Price Target: $206
Current: $169.96
Upside: +21.20%
Jun 27, 2022
Reinstates: Buy
Price Target: $145
Current: $191.21
Upside: -24.17%
Mar 3, 2022
Initiates: Buy
Price Target: $15
Current: $10.75
Upside: +39.53%
Feb 8, 2022
Initiates: Buy
Price Target: $200
Current: $22.09
Upside: +805.39%
Feb 22, 2017
Initiates: Buy
Price Target: $26
Current: $30.88
Upside: -15.80%